Articles

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief

The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy. More 

3 Battery Stocks You’ll Regret Not Buying Soon: December Edition

Battery stocks are expected to rise in value throughout next year and beyond that. Here are three companies to consider. More 

3 Cryptos You’ll Regret Not Buying Soon: December Edition

The best cryptos to buy have strong names and utility and are headed into 2024 much stronger as rates reverse. More 

Why Li Stock Is a Great Pick for Long-Term Investors

Li is growing rapidly, and Li is likely to be one of several Chinese EV makers that will become world-class firms.   More 

SOFI Stock Rebound: Sell Into Strength or Let it Ride?

As sentiment for SOFI stock has quickly shifted back to bullish, let's see whether momentum can stay on its side in 2024. More 

AMD Stock Hits 52-Week High: Time to Buy or Exercise Caution?

As before, feel free to maintain an existing AMD stock position, but for those looking to enter or add to a position, take your time. More 

Lucid Stock Warning: Steer Clear in the New Year

LCID stock doesn't belong on prudent investors' watch lists as Lucid Group loses a key executive and gets booted from a major stock index. More